groups [23-25], and altering the linker length. Moreover, to improve the pharmacological profiles and solubilities of naphthalimide
derivatives while maintaining their inhibitory activity, we replaced the naphthalimide moiety with quinoline carboxamide group via an
intramolecular N-H hydrogen bond to mimic the naphthalimide configuration. We studied the inhibition mechanisms of these compounds
using structure-based molecular docking.
The preparation of substituted naphthalimide derivatives 3a-m is summarized in Scheme 1. The dimethylamine-substituted
intermediate 1b can be obtained from the corresponding commercially available 4-bromo-1,8-naphthalic anhydride 1a. Intermediates 2
were synthesized by reacting a suspension of intermediates 1 in ethanol with excess Boc-protected amines, followed by deprotection in
acidic condition. Compounds 3 were synthesized from intermediates 2 with a halogenated compound or aryl acyl chloride under base
conditions [26].
The quinoline derivatives were prepared according the method described in Scheme 2. The quinoline acyl chloride 4, which was
prepared from quinoline carboxylic acid, was reacted with the Boc-protected amine and then deprotected under acidic condition to obtain
the intermediate 5. Compounds 6 were synthesized from intermediate 5 with the halogenated compounds or aryl acyl chloride under base
1
conditions. Details for the synthetic procedures, physical characteristics and the results of H NMR, 13C NMR and MS for all the
synthesized compounds are listed in the Supporting information.
The inhibitory activities of naphthalimide derivatives 3a-m toward OfHex1 are outlined in Table 1. For substitution of NH (R1), a
comparison of 3a with 3b showed that small rings, such as thiazole, gave better inhibitory activity than the pyridine ring. The carbonyl
group was introduced to increase the hydrogen bond between the compound and the enzyme, which could improve binding affinity.
However, a comparison of 3a with 3c–i showed that replacement of methylene with a carbonyl or sulfone group did not remarkably
improve the inhibitory activity.
Compound 3a had an acceptable level of inhibitory activity, and the raw material of 3a, 2-chloro-5-(chloromethyl)thiazole, is cheap
and easy to get. Thus, we used (2-chlorothiazol-5-yl)methyl as R1 and focused our attention on the effects of the substitution of the
naphthalimide and elongation of the alkyl chain (n). Replacement of the dimethylamino group with bromine or hydrogen at the 5-position
(R2; compound 3j and 3k) decreased the activity against OfHex1. A comparison of the inhibitory activities of compounds 3a, 3l and 3m
showed a large enhancement with elongation of the alkyl chain (n). Compound 3m stood out with comparatively higher activity with a
Ki value of 0.34 μmol/L (Fig. 1A), and exhibited about 4-fold increase in inhibitory activity when compared with compound Q2 (Ki =
1.4 μmol/L).
To improve the pharmacological profiles of naphthalimide derivatives but maintain the inhibitory activity, we replaced the
naphthalimide moiety with quinoline carboxamide group, which contains an intramolecular N-H hydrogen bond and could mimic the
naphthalimide while improving the solubility. The quinoline analogues showed obvious better inhibitory activities against OfHex1,
regardless of their content of a six-membered ring or five-membered ring (Table 2). Compounds containing a thiazole ring, including 6a,
6e and 6j, exhibited more potent inhibitory activity (>70%) than compounds containing other heterocycle ring. Compound 6a showed
the best inhibitory activity with a Ki value of 2.3 μmol/L against OfHex1 (Fig. 1B).
To elucidate the inhibition mechanism of 3m, molecular docking was performed using OfHex1 as template. We found that 3m
occupied the entire substrate binding pocket of OfHex1 and interacted via hydrogen bonds (Fig. 2A). The molecular docking study
revealed good binding of the linker and the thiazole group of 3m at the subsite −1. The linker of 3m was bent into a curved conformation
and the secondary nitrogen atom formed a hydrogen bond with the catalytic residue Glu368 and the residue Glu328. The N3 atom formed
a hydrogen bond with the phenolic hydroxyl group of Tyr475. Interestingly, the length of the linker region had a strong effect on the
inhibition mechanism. Elongation of the alkyl chain resulted in tight binding of the 4-dimethylaminonaphthalimide group of 3m. A
hydrophobic patch comprising Trp483, Trp490 and carbonyl groups from the 4-dimethylaminonaphthalimide formed hydrogen bonds
with Val327, Glu328 and Glu526.
The binding mode of compound 6a in OfHex1 was studied by molecular docking. As shown in Fig. 2B, binding of compound 6a
occurred in the entire active pocket of OfHex1 in a similar manner to compound 3m. The mechanisms of interaction of the linkers and
thiazole group with OfHex1 were similar to those of 3m, and the quinoline group bound with a hydrophobic patch comprising Trp483
and Trp490 outside of subsite −1.
Although compounds 3m (Ki = 0.34 μmol/L) and 6a (Ki = 2.3 μmol/L) showed different inhibitory activity as Q2 did (Ki = 1.4 μmol/L)
against OfHex1, the predicted binding modes of 3m and 6a were similar to that of Q2 in the crystal structure of OfHex1 in a complex
with Q2 [19] (Fig. 2C). First, binding of the thiazole group of 3m, 6a and the thiadiazole group of Q2 occurred in subsite −1 of the active
pocket in the same fashion. These groups were sandwiched by Trp524 and Trp448 and their N3 atoms formed hydrogen bonds with the
phenolic hydroxyl group of Tyr475. Second, the linkers of 3m, 6a and Q2 were bent into a curved conformation and the secondary
nitrogen atoms formed hydrogen bonds with the catalytic residue Glu368. These results suggest that the compounds discovered in this
study inhibit OfHex1 by a similar mechanism as Q2.
In summary, we designed, prepared and evaluated a series of substituted naphthalimide and quinoline derivatives as potential
inhibitors of OfHex1. Compound 3m was the most potent inhibitor with a Ki value of 0.34 µmol/L. Quinoline analogs with an
intramolecular N-H hydrogen bond mimic the naphthalimide configuration to maintain the inhibitory activity potency.